BioLife Solutions Inc
Audentes Therapeutics’ Promising Product Pipeline
In this series, we’ll take a look at six stocks with a focus on gene therapy that have promising products in their pipelines.
BioLife Solutions: On a Strong Footing
BioLife Solutions (BLFS) generated revenues of $5.18 million in the second quarter compared to $2.56 million in Q2 2017.